Clinical Trial Update: Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluated intravenous levosimendan for short-term treatment of decompensated chronic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Abbott | Conditions: Heart Failure, Congestive | Phase 3 | Status: COMPLETED